Reglagene's Pipeline 

Reglagene's platform technology is developing innovative Epigenetic and Epitranscriptomic Medicines that are reversing diseases.

  • These medicines help existing treatments work better and longer.

  • Reglagene's medicines can work as a mono-therapy, but we believe that predictably pairing our drugs with existing cancer therapies will abate cancer symptoms and flatline tumor growth.

  • Reglagene's current focus is on developing oncology medicines, but the platform technology can extend to anti-infectives, fibrosis, cardiovascular, ophthalmology, and CNS diseases.


1703 E Mabel St
Tucson, AZ 85721
USA  | | ©2020 by Reglagene Holding, Inc.